- 1次围观
产品图片
货号/SKU
MRA-202G
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、1
产品描述信息
MRA-202G?? Genomic DNA from Plasmodium falciparum, TM90C2A(Nucleic Acids)|Plasmodium falciparum|Genomic DNA from Plasmodium falciparum, TM90C2A|-20°C or colder|DE KyleAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Genomic DNA from Plasmodium falciparum, Strain TM90C2A, MRA-202G, contributed by Dennis E. Kyle.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Genomic DNA was extracted from a preparation of Plasmodium falciparum (P. falciparum), strain TM90C2A.
P. falciparum, strain TM90C2A was isolated in 1990 from a patient in an atovaquone clinical trial in Thailand upon admission; strain TM90C2A is the first documented failure of atovaquone (alone) in Thailand. P. falciparum, strain TM90C2B was co-isolated with strain TM90C2A, but was isolated following recrudescence. Strain TM90C2A is reported as resistant to chloroquine and mefloquine.
MRA-202G has been qualified for PCR applications by amplification of approximately 900 base pairs of the merozoite surface protein 2 (MSP2) gene.
Each vial of MRA-202G contains approximately 0.5 ?g of genomic DNA in TE buffer (10 mM Tris-HCl and 0.5 mM EDTA, pH 9). The vial should be centrifuged prior to opening.
Genomic DNA was extracted from a preparation of Plasmodium falciparum (P. falciparum), strain TM90C2A.
P. falciparum, strain TM90C2A was isolated in 1990 from a patient in an atovaquone clinical trial in Thailand upon admission; strain TM90C2A is the first documented failure of atovaquone (alone) in Thailand. P. falciparum, strain TM90C2B was co-isolated with strain TM90C2A, but was isolated following recrudescence. Strain TM90C2A is reported as resistant to chloroquine and mefloquine.
MRA-202G has been qualified for PCR applications by amplification of approximately 900 base pairs of the merozoite surface protein 2 (MSP2) gene.
Each vial of MRA-202G contains approximately 0.5 ?g of genomic DNA in TE buffer (10 mM Tris-HCl and 0.5 mM EDTA, pH 9). The vial should be centrifuged prior to opening.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
从制剂中提取基因组DNA 疟原虫（ p. falciparum ），菌株TM90C2A.
p. Falciparum ，菌株TM90C2A于1990年从泰国入场时从Asovaquone临床试验中分离出来;菌株TM90C2A是泰国的第一次记录失败的Atovaquone（单独）. p. Falciparum ，菌株TM90C2B与菌株TM90C2A共隔离，但在复发后分离.菌株TM90C2A被报告为抗氯喹和Mefloquine的抗性.
MRA-202G已通过扩增MEROZOITE表面蛋白2（MSP2）基因的约900碱基对（MSP2）基因授予PCR应用.
MRA-202G的每个小瓶中含有约0.5μg的TE缓冲液中的基因组DNA（10mM Tris-HCl和0.5mM EDTA，pH 9）.在打开之前应该离心小瓶.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-04-01
2022-04-01
2021-12-21
2022-04-01
2022-04-01
2022-04-01
2022-03-31
2021-10-31
2021-12-21
2022-04-01
2024-05-19
2022-04-01
2022-04-01
2024-07-31
2021-12-02
2024-07-31